Translational Success in Inflammasome Drug Discovery: How Advanced Models and Integrated Assays Can Reduce Attrition
Join Professor Luke O’Neill (Trinity College Dublin) and Dr Elise Malavasi ( Associate Director of Neurosciences Concept Life Sciences) for this webinar that explores recent advances in inflammasome science, and highlights how selecting appropriate in vitro models and meaningful readouts is essential for accurately assessing therapeutic potential.
Epigenomics at 360° in Liquid Biopsy: Approaches and Case Studies for Biomarker Discovery and Drug Development
Dr. Matteo Tosolini and Dr. Jessica Apulei from Hologic Diagenode answer questions from their webinar on epigenomics as a dynamic regulatory layer beyond genetics and liquid biopsies as a means of obtaining multimodal biomarker readouts.
Recent Advances in Crystalline Polymorphism Research in Drug Development
This recorded webinar explores recent advances in pharmaceutical development by introducing NGK’s infrared crystal screening technology and Professor Etsuo Yonemochi’s research on crystalline polymorphism and morphology.
Accelerating Antibody Discovery: Integrating Microfluidics, HT Expression, and Early Developability Platform
In this webinar, Dr. Lei Shi introduces Biointron's antibody discovery platform and applications.
Improving Confidence in Thyroid Hormone Disruption Assessment Using a Novel Human-Relevant In Vitro Model
Learn how an emerging NAM is helping advance more efficient, human-relevant strategies for assessing thyroid hormone disruption while reducing reliance on animal testing.
Accelerating Conjugation Process Development for Next-Generation ADCs: Key Considerations and Platform Strategies
In this webinar, Dr. Peng reviews the current ADC landscape and share key considerations and platform strategies to accelerate conjugation process development for next-gen ADCs.
High‑Throughput RT‑qPCR and Transcriptomics: Powering the Next Generation of Drug Discovery
In this webinar, Dr. Timur Samatov and Dr. Xavier Maréchal discuss how a fully transcriptomics enabled workflow can advance mRNA driven discovery and speed progression from screening to candidate nomination.
Epigenomics at 360° in Liquid Biopsy: Approaches and Case Studies for Biomarker Discovery and Drug Development
In this talk, we highlight epigenomics as a dynamic regulatory layer beyond genetics and demonstrate how minimally invasive liquid biopsies can provide multimodal biomarker readouts.
ADC Payload-Linker CMC Process Development Strategy
Hear Dr. Zheng Wei share a comprehensive payload-linker CMC development strategy that covers regulatory guidance, RSM selection, and stage-appropriate quality control to navigate the evolving complexities of ADC design from IND to NDA.
ADCs on The Horizon: The Performance and Prospect of Cell Line Development Platform — AmigoCHO™
Dr. Jiawen Xu presents AsymBio’s AmigoCHO™ platform and "CLD toolbox" strategies designed to accelerate cell line development and overcome CMC bottlenecks for complex antibody and ADC programs.
From Single Domain to Single B: Leveraging Biointron’s Expertise for Antibody Discovery Success
In this webinar, we present Biointron’s proven expertise in two discovery approaches: VHH Phage Display for single-domain antibody generation and AbDrop® Single B Cell Screening for rapid antibody discovery.
Uniting biology and digital drug discovery to identify new therapeutic opportunities in neurodegeneration
As the FDA and NIH encourage a shift away from animal testing, there’s growing momentum behind New Approach Methodologies (NAMs) — from advanced in vitro models to computational platforms. In this webinar, Concept Life Sciences and Delta4 present a powerful example of what this future looks like in practice.
Novel Applications of the Cellular Thermal Shift Assay (CETSA) Provide New Insights for Drug Discovery
Join AbbVie scientists Shitalben Patel and Jami R. Erickson as they showcase their innovative advancements, transforming CETSA® into a high-throughput flow-based platform and introducing new whole blood formats to elevate drug discovery.
Integrating Regulatory Guidance and Sustainable Skin Procurement for Consistent Execution of In Vitro Permeation Testing
Join LifeNet Health LifeSciences for our first Assay Services webinar, focusing on Dermal Absorption. This session explores in vitro permeation testing, a crucial method for assessing a compound’s potential to penetrate the skin and reach systemic circulation.
Improved Clearance Predictions for Aldehyde Oxidase Substrates Using TruVivo, a Novel Human Hepatocyte Model
In this exclusive session, Stephanie Piekos, PhD, Senior Scientist at Boehringer Ingelheim, shares insights into the challenges of evaluating AO substrates and how more predictive, human-relevant models are shaping the future of DMPK studies.
Introduction to Bispecific Antibodies and Their Production
In this webinar, Dr. Brady Wu discusses bispecific antibody drugs and their production.
Empowering Drug Hunters with High-Throughput Protein Crystallography
Watch this webinar by Concept Life Sciences, hosted by Dr. Thomas Pesnot (Concept Life Sciences) and featuring Dr. Debanu Das from Accelero Biostructure, Inc as keynote speaker.
Supporting the Development of Biologics Through the IND‑Enabling Studies and Clinical Phases
In this webinar, Dr. Linda Randall shares how Pharmaron’s global teams are supporting the development of biological drugs from discovery to commercial supply.
The ADMET Toolkit: Impact on Compound Design and Optimisation
Watch this webinar by Concept Life Sciences, hosted by Dr. Thomas Pesnot (Concept Life Sciences) and featuring Dr. Rob Riley as keynote speaker, on the ADMET Toolkit for clinical pharmacokinetics.
From Bench to Clinic: Decoding the IND Roadmap for Innovative Cell and Gene Therapies
Join Dr. Grace Lee and Dr. Frederik Deroose as they discuss important considerations and challenges during the Investigational New Drug (IND) application process, with a focus on cell and gene therapy.
Innovative Approaches to Assessing Thyroid Disruption: The 3D Human Thyroid Microtissue Model
Dr. Chad Deisenroth, PhD, from the US EPA, introduces an advanced human in vitro 3D thyroid microtissue model designed to evaluate thyroid hormone disruption, addressing current challenges with existing models.
The Sweet Truth: Unwrapping the Science of Semaglutide
Semaglutide, also known as Ozempic and Wegovy, has become increasingly popular -- but why? Here we discuss the mechanism behind these drugs, how they've become so well known, and what current research says about their long-term effects.
Evaluation of TruVivo, an All-Human Hepatocyte Model for Mechanistic DMPK Investigations
Join Diane Ramsden, PhD, and Lindsey Whaley, MS, for an inside look at TruVivo™, a novel all-human in vitro hepatocyte system developed by LifeNet Health LifeSciences.
#ExpertAnswers: Frauke Greve and Anna Borgström on Hepatic Safety Using 3D Liver Spheroids
Frauke Greve and Anna Borgström from InSphero highlight the latest advancements in hepatic safety assessment using 3D liver spheroids.
What Every Researcher Needs to Know About Using Medicare Data for Real World Evidence
Join three panelists who provide a practical overview of how and why to use data from Medicare for real world studies.
